Understanding Renal Disorders

Learning Objectives

• Classify Acute Kidney Injury (AKI) into pre-renal, intrinsic renal, and post-renal causes with clinical clues for each.
• Stage Chronic Kidney Disease (CKD) using GFR criteria and list its major causes.
• Differentiate nephrotic syndrome from nephritic syndrome (glomerulonephritis) by clinical and urinary findings.
• Interpret basic electrolyte disturbances (hyperkalemia, hyponatremia) seen in renal failure.
• Select appropriate first-line investigations for a patient presenting with abnormal renal function.
• Recognize indications for dialysis in acute and chronic kidney disease.

Quick Answer

Renal disorders range from sudden, often reversible drops in kidney function (Acute Kidney Injury) to slow, permanent decline (Chronic Kidney Disease), plus glomerular diseases like nephrotic and nephritic syndromes that damage the filtering units directly. They matter because the kidney controls fluid balance, electrolytes, acid-base status, and waste clearance — when it fails, every organ system feels it, from the heart (hyperkalemia, fluid overload) to the brain (uremic encephalopathy). Recognizing the pattern quickly (pre-renal vs renal vs post-renal, nephrotic vs nephritic) is what lets you pick the right test and the right treatment before permanent damage sets in.

Overview of the Kidneys

Before diving into specific renal disorders, it helps to remember what the kidney actually does day to day, because every disorder below is really a failure of one of these jobs.

• The kidneys are bean-shaped organs in the retroperitoneum, one on each side of the spine, each about 10-12 cm long and 150 g.
• Each kidney contains roughly 1 million nephrons — the functional filtration units — made of a glomerulus (filter) and a tubule (reabsorption/secretion).
• Together they filter about 180 L of plasma per day, regulate fluid and electrolyte balance, maintain acid-base status, excrete nitrogenous waste, and produce erythropoietin and activated vitamin D.

Acute Kidney Injury (AKI)

AKI is a sudden (hours to days) drop in kidney function, usually defined as a rise in serum creatinine of ≥0.3 mg/dL within 48 hours, a ≥1.5x rise from baseline within 7 days, or urine output <0.5 mL/kg/hr for 6 hours. The key skill is localizing where the problem is, because the three categories have almost opposite management.

• Pre-renal (~55-60% of cases): The kidney tissue is healthy but under-perfused — dehydration, hemorrhage, heart failure, sepsis, or NSAID/ACE-inhibitor use narrowing renal blood flow. Urine is concentrated, FENa <1%, and it reverses quickly once perfusion is restored.
• Intrinsic renal (~35-40%): Actual damage to glomeruli, tubules, interstitium, or vessels. Acute tubular necrosis (from prolonged ischemia or nephrotoxins like aminoglycosides and contrast dye) is the most common cause. FENa is typically >2%, and muddy brown casts on urine microscopy are classic for ATN.
• Post-renal (~5-10%): Obstruction anywhere from the renal pelvis to the urethra — stones, benign prostatic hyperplasia, tumors, strictures. Bilateral obstruction (or unilateral in a solitary kidney) is needed to raise creatinine; ultrasound showing hydronephrosis clinches it.

Symptoms include decreased urine output, peripheral edema, fatigue, nausea and vomiting, and confusion in severe cases. Management always starts with treating the underlying cause (fluids for pre-renal, relieving obstruction for post-renal, stopping nephrotoxins for intrinsic), plus supportive care — correcting electrolytes and fluid balance, and dialysis if refractory hyperkalemia, severe acidosis, fluid overload, uremic symptoms, or refractory acidosis develop (remember "AEIOU").

Chronic Kidney Disease (CKD)

CKD is kidney damage or GFR <60 mL/min/1.73m² persisting for more than 3 months — the time criterion is what separates it from AKI, and it's often irreversible.

Stage	GFR (mL/min/1.73m²)	Description
1	≥90	Kidney damage with normal GFR
2	60-89	Mild decrease in GFR
3a/3b	30-59	Moderate decrease
4	15-29	Severe decrease
5	<15 (or on dialysis)	Kidney failure (ESRD)

The two biggest drivers of CKD worldwide are diabetes mellitus and hypertension — together they cause roughly two-thirds of cases — followed by glomerulonephritis and polycystic kidney disease. As GFR falls, patients develop anemia (loss of erythropoietin), renal osteodystrophy (loss of activated vitamin D and phosphate retention), metabolic acidosis, and eventually uremia. Management is about slowing progression (blood pressure and glucose control, ACE inhibitors/ARBs to reduce proteinuria, dietary protein and phosphate restriction) and, in stage 5, renal replacement therapy — dialysis or transplantation.

Glomerular Diseases: Nephrotic vs. Nephritic

Glomerulonephritis is inflammation of the glomeruli, and it presents as one of two clinical patterns that are frequently mixed up but are diagnosed and managed differently.

Nephrotic syndrome — the glomerular basement membrane's charge/size barrier is damaged, leaking large amounts of protein:

• Heavy proteinuria (>3.5 g/day), hypoalbuminemia, and edema (the classic triad), plus hyperlipidemia and a hypercoagulable state (loss of antithrombin III).
• Causes: minimal change disease (most common in children), focal segmental glomerulosclerosis, membranous nephropathy, and secondary causes like diabetes and lupus.
• Treatment: corticosteroids (especially effective in minimal change disease), immunosuppressants, ACE inhibitors/ARBs to reduce proteinuria, and salt restriction with diuretics for edema.

Nephritic syndrome — an inflammatory process damages the glomerulus enough to let blood cells through:

• Hematuria (often with dysmorphic RBCs and red cell casts), mild-to-moderate proteinuria, hypertension, and oliguria.
• Causes: post-streptococcal glomerulonephritis, IgA nephropathy (the most common glomerulonephritis worldwide), lupus nephritis, and Goodpasture's syndrome (anti-GBM disease with lung hemorrhage).
• Treatment varies by cause but often includes blood pressure control, immunosuppression for autoimmune causes, and treating the underlying infection in PSGN.

Electrolyte Disorders in Renal Disease

Failing kidneys can't excrete potassium, retain sodium and water appropriately, or regulate acid-base balance, so electrolyte derangements are where renal disease becomes acutely dangerous.

• Hyperkalemia: The most immediately life-threatening complication of AKI/CKD — peaked T waves and widened QRS on ECG signal a cardiac emergency. Treated with IV calcium gluconate (membrane stabilization), insulin-glucose and beta-agonists (shift potassium into cells), and dialysis for definitive removal.
• Hyponatremia/volume overload: Reduced free water excretion causes dilutional hyponatremia and fluid retention, presenting as edema, hypertension, and pulmonary congestion.
• Metabolic acidosis: Reduced acid excretion and bicarbonate regeneration cause a high-anion-gap acidosis, contributing to fatigue and hyperventilation (Kussmaul breathing in severe cases).
• Hyperphosphatemia and hypocalcemia: Seen in CKD due to reduced phosphate excretion and reduced activation of vitamin D, driving secondary hyperparathyroidism and renal osteodystrophy.

Diagnosis and Assessment

• Urinalysis: proteinuria, hematuria, casts (muddy brown = ATN, red cell casts = glomerulonephritis, waxy casts = CKD).
• Blood tests: creatinine, urea, electrolytes, and estimated GFR.
• FENa (fractional excretion of sodium): <1% suggests pre-renal, >2% suggests intrinsic renal (ATN).
• Imaging: renal ultrasound is first-line to rule out obstruction (hydronephrosis) and assess kidney size (small, scarred kidneys suggest chronicity).
• Renal biopsy: reserved for unexplained glomerular disease or rapidly progressive renal failure where the diagnosis changes management.

Key Terms

Term	Definition
GFR (Glomerular Filtration Rate)	Volume of fluid filtered by the glomeruli per unit time; the primary marker of kidney function.
Creatinine	A muscle breakdown product freely filtered by the kidney; used to estimate GFR.
FENa	Fractional excretion of sodium; helps distinguish pre-renal AKI from intrinsic renal AKI.
Proteinuria	Abnormal protein loss in urine; hallmark of glomerular damage, especially nephrotic syndrome.
Azotemia	Elevated blood urea and creatinine, with or without symptoms; precedes overt uremia.
Uremia	The clinical syndrome of symptomatic kidney failure — nausea, confusion, pericarditis, from retained waste products.
Dialysis	Artificial process (hemodialysis or peritoneal dialysis) that removes waste and excess fluid when kidneys cannot.
Hydronephrosis	Dilation of the renal pelvis/calyces from obstructed urine flow; the imaging hallmark of post-renal AKI.

Common Mistakes

1. Misconception: "AKI and CKD are the same thing, just different severities." Why it's wrong: Severity isn't what separates them — duration and reversibility are. A patient can have severe AKI that fully resolves, or mild but permanent CKD. Correct: AKI is defined by an abrupt change (hours to days) that is often reversible; CKD requires damage or reduced GFR persisting beyond 3 months and is usually progressive. Always check baseline creatinine before labeling a rise as "chronic."

2. Misconception: "Proteinuria and hematuria on a urine dipstick mean the same underlying process." Why it's wrong: Students often lump all glomerular disease together, but the two findings point to different mechanisms and diseases. Correct: Heavy, isolated proteinuria with edema points to nephrotic syndrome (podocyte/basement membrane injury); hematuria with red cell casts and hypertension points to nephritic syndrome (inflammatory glomerular injury). Some diseases (like diffuse proliferative lupus nephritis) can show a mixed picture, but the default teaching split matters for exams.

3. Misconception: "All AKI needs dialysis." Why it's wrong: This overestimates how sick most AKI patients are and ignores that most pre-renal AKI resolves with simple fluid resuscitation. Correct: Dialysis is reserved for specific indications — refractory hyperkalemia, severe metabolic acidosis, fluid overload unresponsive to diuretics, uremic complications (encephalopathy, pericarditis), or certain toxin ingestions. Most AKI is managed conservatively by treating the underlying cause.

Comparison and Connections

Feature	Pre-renal AKI	Intrinsic AKI (ATN)	Post-renal AKI
Mechanism	Reduced renal perfusion	Direct tubular/glomerular injury	Obstructed urine outflow
FENa	<1%	>2%	Variable, often >1%
Urine sediment	Bland, hyaline casts	Muddy brown granular casts	Often bland; may see crystals/blood
Response to fluids	Improves	No improvement	No improvement; needs decompression

Feature	Nephrotic Syndrome	Nephritic Syndrome
Hallmark	Heavy proteinuria (>3.5 g/day)	Hematuria with RBC casts
Edema	Prominent (periorbital, generalized)	Mild, with hypertension
Serum albumin	Low	Usually normal or mildly low
Classic example	Minimal change disease	Post-streptococcal GN

Practice Questions

Recall

1. What creatinine and urine output criteria define AKI? Answer guidance: ≥0.3 mg/dL rise in 48h, or ≥1.5x baseline in 7 days, or urine output <0.5 mL/kg/hr for 6 hours.
2. Name the five stages of CKD and their approximate GFR ranges. Answer guidance: Stage 1 (≥90), Stage 2 (60-89), Stage 3 (30-59), Stage 4 (15-29), Stage 5 (<15/ESRD).

Understanding 3. Why does pre-renal AKI typically have a FENa below 1% while intrinsic AKI has a FENa above 2%? Answer guidance: In pre-renal AKI, tubules are intact and avidly reabsorb sodium to conserve volume in response to hypoperfusion; in ATN, damaged tubules cannot reabsorb sodium normally, so more is lost in urine. 4. Explain why nephrotic syndrome causes a hypercoagulable state. Answer guidance: Loss of antithrombin III (and other anticoagulant proteins) in urine alongside increased hepatic synthesis of clotting factors tips the balance toward thrombosis, notably renal vein thrombosis.

Application 5. A dehydrated elderly patient on an NSAID and an ACE inhibitor develops a creatinine rise. What type of AKI is most likely, and what is the first management step? Answer guidance: Pre-renal AKI from combined reduced renal perfusion (dehydration, NSAID-induced afferent arteriole constriction) and reduced glomerular pressure (ACE inhibitor); stop the offending drugs and give IV fluids. 6. A child presents with periorbital edema, frothy urine, and a normal blood pressure. What is the likely diagnosis and first-line treatment? Answer guidance: Minimal change disease (nephrotic syndrome); first-line treatment is corticosteroids, to which children typically respond well.

Analysis 7. Compare how you would distinguish AKI from CKD in a patient presenting with a creatinine of 6 mg/dL and no prior records. Answer guidance: Look for markers of chronicity — small/scarred kidneys on ultrasound, anemia, hypocalcemia/hyperphosphatemia, and waxy casts suggest CKD; normal-sized kidneys and an acute clinical trigger (sepsis, contrast, obstruction) suggest AKI. 8. A patient with CKD stage 4 develops peaked T waves on ECG. Analyze the immediate risk and justify the treatment sequence. Answer guidance: This indicates hyperkalemia, a cardiac emergency risking arrhythmia/arrest; sequence is IV calcium gluconate first to stabilize the myocardial membrane, then insulin-glucose/beta-agonists to shift potassium intracellularly, then dialysis for definitive removal since calcium and shifting agents don't remove potassium from the body.

FAQ

1. Is AKI always reversible? Not always, but most pre-renal and many intrinsic causes (like uncomplicated ATN) recover kidney function over days to weeks once the trigger is removed. Severe or prolonged injury can leave residual CKD.

2. Why do ACE inhibitors sometimes cause AKI instead of protecting the kidneys? ACE inhibitors dilate the efferent arteriole, which normally reduces glomerular pressure and is protective long-term in CKD. But in a patient who is already volume-depleted or has bilateral renal artery stenosis, that same efferent dilation drops filtration pressure enough to cause acute injury.

3. What's the difference between azotemia and uremia? Azotemia is the lab finding of elevated urea and creatinine; uremia is the symptomatic clinical syndrome (nausea, confusion, pericarditis, pruritus) that occurs when azotemia becomes severe enough to cause organ dysfunction.

4. Why is IgA nephropathy often missed early? It frequently presents with episodic gross hematuria 1-2 days after a upper respiratory infection ("synpharyngitic hematuria") rather than the classic latency of post-streptococcal GN (1-3 weeks), and mild cases can be asymptomatic between flares.

5. Can a patient have both nephrotic and nephritic features at once? Yes — conditions like diffuse proliferative lupus nephritis or severe post-streptococcal GN can produce heavy proteinuria alongside hematuria and hypertension, creating a mixed picture that still needs biopsy for definitive classification.

Quick Revision

• AKI = abrupt (hours-days) kidney function decline; CKD = damage/low GFR for >3 months.
• Three AKI categories: pre-renal (perfusion), intrinsic (tissue damage, mostly ATN), post-renal (obstruction).
• FENa <1% = pre-renal; FENa >2% = intrinsic renal (ATN).
• Muddy brown granular casts = ATN; red cell casts = glomerulonephritis; waxy casts = CKD.
• CKD staged 1-5 by GFR; diabetes and hypertension cause ~two-thirds of cases.
• Nephrotic syndrome = heavy proteinuria + hypoalbuminemia + edema + hyperlipidemia + hypercoagulability.
• Nephritic syndrome = hematuria + RBC casts + hypertension + mild proteinuria.
• Minimal change disease = most common nephrotic cause in children; responds well to steroids.
• IgA nephropathy = most common glomerulonephritis worldwide.
• Hyperkalemia is the most acutely dangerous electrolyte disturbance in renal failure; treat with calcium, insulin-glucose, then dialysis.
• Dialysis indications: refractory hyperkalemia, acidosis, fluid overload, uremic symptoms, certain toxins.
• Ultrasound is first-line imaging to exclude obstruction in any new AKI.

Related Topics

Prerequisites

• Basic renal physiology and nephron anatomy
• Acid-base balance and electrolyte physiology
• Fluid compartments and volume status assessment

Related Topics

• Hypertension and its renal effects
• Diabetes mellitus and diabetic nephropathy
• Fluid and electrolyte disorders

Next Topics

• Renal replacement therapy (dialysis modalities and transplantation)
• Urological disorders (stones, obstruction, BPH)
• Systemic diseases with renal involvement (lupus, vasculitis, amyloidosis)